Investigational Site Number :0320002

Caba C1425BEN

0 studies enrolling now · 8 studies all time

What they study most

Asthma, Chronic Kidney Diseases, Chronic Obstructive Pulmonary Disease, Giant Cell Arteritis, Heart Failure, Polymyalgia Rheumatica, Sphingomyelin Lipidosis, Systemic Sclerosis, Type 2 Diabetes Mellitus

Studies at this site

• A Prospective and Retrospective Cohort Study in Patients With Chronic Forms of Acid Sphingomyelinase Deficiency (ASMD) — Completed
• Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of SAR440340 (Anti-IL-33 mAb) in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD) — Completed
• Effect of Sotagliflozin on Cardiovascular and Renal Events in Participants With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk — Stopped early
• Evaluation of SAR440340 and as Combination Therapy With Dupilumab in Moderate-to-Severe Asthma Participants — Completed
• Evaluation of the Efficacy and Safety of Sarilumab in Patients With Polymyalgia Rheumatica — Stopped early
• Evaluation of Efficacy and Safety of Sarilumab in Patients With GCA — Stopped early
• Effectiveness and Safety of SAR156597 in Treating Diffuse Systemic Sclerosis — Completed
• Effect of Efpeglenatide on Cardiovascular Outcomes — Stopped early